RPG Life Sciences Cash Flow Annual

BSE: 532983 | NSE: RPGLIFE | ISIN: INE105J01010 | Sector: Biotechnology & Drugs

2,726.55 +9.15 (0.34%)Updated : 16 Sep 2026

Research on

Interim Data

Annual Data

Fiscal Period	2026	2025	2024	2023
Period End Date	Mar 26	Mar 25	Mar 24	Mar 23
Issuance( Retirement)of Debt Net	20.00	0.00	-0.01	-0.93
Net Changein Cash	121.76	8.98	-5.10	-32.12
Cash Taxes Paid	37.22	52.75	29.31	25.23
Net Income/ Starting Line	154.20	232.88	117.84	91.68
Total Cash Dividends Paid	-39.69	-26.46	-19.85	-15.88
Changesin Working Capital	-80.39	-78.80	-36.40	-14.18
Cashfrom Operating Activities	56.50	77.86	94.36	90.81
Cash Interest Paid	0.89	0.62	0.45	0.31
Cashfrom Financing Activities	-20.58	-27.08	-20.31	-17.12
Depreciation/ Depletion	21.48	21.43	17.07	15.50
Other Investing Cash Flow Items Total	151.20	-5.77	-9.92	-73.08
Capital Expenditures	-65.36	-36.03	-69.23	-32.73
period Type	-	-	-	-
Non- Cash Items	-38.79	-97.65	-4.15	-2.19
Financing Cash Flow Items	-0.89	-0.62	-0.45	-0.31
period Length	12.00	12.00	12.00	12.00
Cashfrom Investing Activities	85.84	-41.80	-79.15	-105.81

*All figures in crores except per share values

Trending Stocks

264.35+6.35(2.46%)

991.10+21.70(2.24%)

1,243.95+23.60(1.93%)

2,191.50-58.50 (-2.60%)

1,060.65-15.35 (-1.43%)

Related News